Market Estimates
Valuation Metrics
Financials
Trading Trends
CDTX News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Cidara Therapeutics Inc (CDTX) stock price today?
The current price of CDTX is 0 USD — it has increased 0.03 % in the last trading day.
What is Cidara Therapeutics Inc (CDTX)'s business?
Cidara Therapeutics, Inc. is a biotechnology company. The Company is using its Cloudbreak platform to develop drug-Fc conjugate (DFC), immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. The Company’s Cloudbreak platform enables development of DFCs that inhibit specific disease targets while simultaneously engaging the immune system. The Company’s lead DFC candidate CD388, is a highly potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which has completed Phase I and Phase IIa clinical trials. Its oncology DFC candidate, CBO421, is a development candidate targeting CD73 for the treatment of solid tumors. Its Cloudbreak platform creates single molecule cocktails by coupling targeted small molecules and peptides to a human antibody fragment (Fc). The Company is also advancing multiple preclinical and discovery programs targeting cancer and autoimmune diseases.
What is the price predicton of CDTX Stock?
Wall Street analysts forecast CDTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CDTX is 209.67 USD with a low forecast of 173.00 USD and a high forecast of 221.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Cidara Therapeutics Inc (CDTX)'s revenue for the last quarter?
Cidara Therapeutics Inc revenue for the last quarter amounts to 0.00 USD, decreased % YoY.
What is Cidara Therapeutics Inc (CDTX)'s earnings per share (EPS) for the last quarter?
Cidara Therapeutics Inc. EPS for the last quarter amounts to -3.10 USD, increased 26.53 % YoY.
What changes have occurred in the market's expectations for Cidara Therapeutics Inc (CDTX)'s fundamentals?
How many employees does Cidara Therapeutics Inc (CDTX). have?
Cidara Therapeutics Inc (CDTX) has 38 emplpoyees as of January 11 2026.
What is Cidara Therapeutics Inc (CDTX) market cap?
Today CDTX has the market capitalization of 51.05M USD.



![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260109150349_ff7278d56cdb1486ed7799e25c34d985.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260102160449_fd631ca9cc459953cfe9cd75ca0ad768.jpg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260102150649_8babcfee106f928d2938c35b91f7ba0e.jpeg&w=384&q=75)